This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Acute Lung Injury , 2 publications
- Respiratory Distress Syndrome , 2 publications
- Critical Illness , 2 publications
- Anti-Bacterial Agents , 1 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to鈥�
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - 64 Years
- Sexes
- All
My publications
Filter publications
11 publications
2011
Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community.
Chest
鈥�2011
Long-term survival in patients with tracheostomy and prolonged mechanical ventilation in Olmsted County, Minnesota.
Respiratory care
鈥�2011
Mapping physicians' admission diagnoses to structured concepts towards fully automatic calculation of acute physiology and chronic health evaluation score.
BMJ open
鈥�2010
Towards the prevention of acute lung injury: a population based cohort study protocol.
BMC emergency medicine
鈥�2009
Alcohol consumption and development of acute respiratory distress syndrome: a population-based study.
International journal of environmental research and public health
鈥�